The recombinant human (EGF) market is estimated to be valued at US$ 12246.47 Mn in 2023 and is expected to exhibit a CAGR of 9.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. The recombinant human (EGF) market is estimated to be valued at US$ 12246.47 Mn in 2023 and is expected to exhibit a CAGR of 9.3% over the forecast period...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian